{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:34:33Z","timestamp":1782732873397,"version":"3.54.5"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA247796"],"award-info":[{"award-number":["P30CA247796"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1KL2TROO1429"],"award-info":[{"award-number":["1KL2TROO1429"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018776","name":"Cancer Center, University of Florida Health","doi-asserted-by":"publisher","award":["381.915"],"award-info":[{"award-number":["381.915"]}],"id":[{"id":"10.13039\/100018776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semcancer.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:06:35Z","timestamp":1700237195000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mathematical modeling of cardio-oncology: Modeling the systemic effects of cancer therapeutics on the cardiovascular system"],"prefix":"10.1016","volume":"97","author":[{"given":"Camara L.","family":"Casson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia A.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan C.","family":"Ferrall-Fairbanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2023.11.004_bib1","unstructured":"Howlader N. et al. SEER Cancer Statistics Review, 1975\u20132016. National Cancer Institute. seer.cancer.gov\/csr\/1975_2016\/ (accessed Sep 22, 2019)."},{"key":"10.1016\/j.semcancer.2023.11.004_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","author":"Strongman","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.semcancer.2023.11.004_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006915","article-title":"Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies","volume":"vol. 6","author":"Florido","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"19","key":"10.1016\/j.semcancer.2023.11.004_bib4","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1200\/JCO.2014.58.9465","article-title":"Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older patients with breast cancer","volume":"vol. 33","author":"Chavez-MacGregor","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.11.004_bib5","series-title":"Guyton and Hall textbook of medical physiology","author":"Hall","year":"2015"},{"key":"10.1016\/j.semcancer.2023.11.004_bib6","series-title":"Biomedical Mass Transport and Chemical Reaction: Physicochemical Principles and Mathematical Modeling","author":"Ultman","year":"2016"},{"key":"10.1016\/j.semcancer.2023.11.004_bib7","series-title":"Quantitative Human Physiology: An Introduction","author":"Feher","year":"2017"},{"key":"10.1016\/j.semcancer.2023.11.004_bib8","series-title":"Cardiovascular Physiology","author":"Pappano","year":"2019"},{"issue":"4","key":"10.1016\/j.semcancer.2023.11.004_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1113\/jphysiol.1952.sp004764","article-title":"A quantitative description of membrane current and its application to conduction and excitation in nerve","volume":"vol. 117","author":"Hodgkin","year":"1952","journal-title":"J. Physiol."},{"key":"10.1016\/j.semcancer.2023.11.004_bib10","series-title":"Medical Physiology: A Cellular and Molecular Approach","author":"Boron","year":"2012"},{"issue":"843","key":"10.1016\/j.semcancer.2023.11.004_bib11","first-page":"136","article-title":"The heat of shortening and the dynamic constants of muscle","volume":"vol. 126","author":"Hill","year":"1938","journal-title":"Proc. R. Soc. B"},{"key":"10.1016\/j.semcancer.2023.11.004_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0096-4174(18)30128-8","article-title":"Muscle structure and theories of contraction","volume":"vol. 7","author":"Huxley","year":"1957","journal-title":"Prog. Biophys. Biophys. Chem."},{"key":"10.1016\/j.semcancer.2023.11.004_bib13","series-title":"A First Course in Systems Biology","author":"Voit","year":"2018"},{"issue":"17","key":"10.1016\/j.semcancer.2023.11.004_bib14","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1016\/S0021-9258(18)99129-5","article-title":"Hormone-induced calcium oscillations in liver cells can be explained by a simple one pool model","volume":"vol. 266","author":"Somogyi","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0005-2728(94)90073-6","article-title":"A dialogue on Ca2+ oscillations: an attempt to understand the essentials of mechanisms leading to hormone-induced intracellular Ca2+ oscillations in various kinds of cell on a theoretical level","volume":"vol. 1183","author":"Stucki","year":"1994","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.semcancer.2023.11.004_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0006-3495(92)81615-6","article-title":"Theory of excitation-contraction coupling in cardiac muscle","volume":"vol. 63","author":"Stern","year":"1992","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1085\/jgp.113.3.469","article-title":"Local control models of cardiac excitation-contraction coupling. A possible role for allosteric interactions between ryanodine receptors","volume":"vol. 113","author":"Stern","year":"1999","journal-title":"J. Gen. Physiol."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0006-3495(98)77832-4","article-title":"Cardiac Ca2+ dynamics: the roles of ryanodine receptor adaptation and sarcoplasmic reticulum load","volume":"vol. 74","author":"Jafri","year":"1998","journal-title":"Biophys. J."},{"issue":"6","key":"10.1016\/j.semcancer.2023.11.004_bib19","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0006-3495(02)75301-0","article-title":"An integrative model of the cardiac ventricular myocyte incorporating local control of Ca2+ release","volume":"vol. 83","author":"Greenstein","year":"2002","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/CIRCRESAHA.110.223578","article-title":"Integrative systems models of cardiac excitation-contraction coupling","volume":"vol. 108","author":"Greenstein","year":"2011","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2023.11.004_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00923","article-title":"Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview","volume":"vol. 9","author":"Salmaso","year":"2018","journal-title":"Front Pharm."},{"issue":"7","key":"10.1016\/j.semcancer.2023.11.004_bib22","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"vol. 20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.semcancer.2023.11.004_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"vol. 20","author":"Pinzi","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-2828(90)91460-O","article-title":"The basic shape of the arterial pulse. First treatise: mathematical analysis. 1899","volume":"vol. 22","author":"Frank","year":"1990","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.semcancer.2023.11.004_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11517-008-0359-2","article-title":"The arterial Windkessel","volume":"vol. 47","author":"Westerhof","year":"2009","journal-title":"Med Biol. Eng. Comput."},{"issue":"23","key":"10.1016\/j.semcancer.2023.11.004_bib26","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1111\/bph.12996","article-title":"The virtual heart as a platform for screening drug cardiotoxicity","volume":"vol. 172","author":"Yuan","year":"2015","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib27","doi-asserted-by":"crossref","first-page":"H1088","DOI":"10.1152\/ajpheart.00109.2006","article-title":"Alternans and spiral breakup in a human ventricular tissue model","volume":"vol. 291","author":"ten Tusscher","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"23","key":"10.1016\/j.semcancer.2023.11.004_bib28","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1088\/0031-9155\/51\/23\/014","article-title":"Cell model for efficient simulation of wave propagation in human ventricular tissue under normal and pathological conditions","volume":"vol. 51","author":"Tusscher","year":"2006","journal-title":"Phys. Med Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2023.11.004_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbrc.2004.07.176","article-title":"In silico study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium current","volume":"vol. 322","author":"Zhang","year":"2004","journal-title":"Biochem Biophys. Res Commun."},{"issue":"5","key":"10.1016\/j.semcancer.2023.11.004_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4196\/kjpp.2019.23.5.295","article-title":"Clinical and pharmacological application of multiscale multiphysics heart simulator, UT-Heart","volume":"vol. 23","author":"Okada","year":"2019","journal-title":"Korean J. Physiol. Pharm."},{"key":"10.1016\/j.semcancer.2023.11.004_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00997","article-title":"Application of pharmacokinetic-pharmacodynamic modeling in drug delivery: development and challenges","volume":"vol. 11","author":"Zou","year":"2020","journal-title":"Front Pharm."},{"issue":"6","key":"10.1016\/j.semcancer.2023.11.004_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mcp.2000.111481","article-title":"Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women","volume":"vol. 68","author":"Nagaraja","year":"2000","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.semcancer.2023.11.004_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods","volume":"vol. 2","author":"Mould","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"issue":"6","key":"10.1016\/j.semcancer.2023.11.004_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/psp4.12426","article-title":"Quantitative systems pharmacology: an exemplar model-building workflow with applications in cardiovascular, metabolic, and oncology drug development","volume":"vol. 8","author":"Helmlinger","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"10.1016\/j.semcancer.2023.11.004_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.41","article-title":"Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development","volume":"vol. 2","author":"Jones","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"issue":"4","key":"10.1016\/j.semcancer.2023.11.004_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"vol. 22","author":"Pai","year":"2000","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.semcancer.2023.11.004_bib37","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3934\/mbe.2022080","article-title":"Mathematical modeling and machine learning for public health decision-making: the case of breast cancer in Benin","volume":"vol. 19","author":"Agossou","year":"2022","journal-title":"Math. Biosci. Eng."},{"key":"10.1016\/j.semcancer.2023.11.004_bib38","doi-asserted-by":"crossref","unstructured":"M.I.A. Fathoni, Gunardi, F.A. Kusumo, and S.H. Hutajulu, Mathematical model analysis of breast cancer stages with side effects on heart in chemotherapy patients, AIP Conference Proceedings, vol. 2192, no. 1, p. 060007, 2019\/12\/19 2019, doi: 10.1063\/1.5139153.","DOI":"10.1063\/1.5139153"},{"key":"10.1016\/j.semcancer.2023.11.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00799","article-title":"In silico assessment of efficacy and safety of ikur inhibitors in chronic atrial fibrillation: role of kinetics and state-dependence of drug binding","volume":"vol. 8","author":"Ellinwood","year":"2017","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.semcancer.2023.11.004_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bph.14104","article-title":"Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model","volume":"vol. 175","author":"Fernandez-Chas","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"10","key":"10.1016\/j.semcancer.2023.11.004_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0161-5890(01)00108-0","article-title":"Calcium and oxidative stress: from cell signaling to cell death","volume":"vol. 38","author":"Ermak","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcancer.2023.11.004_bib42","article-title":"Accelerating Digitalization in Healthcare with the InSilicoTrials Cloud-Based Platform: Four Use Cases","author":"Nicolo","year":"2022","journal-title":"Ann. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42799-2","article-title":"Modelling changes in glutathione homeostasis as a function of quinone redox metabolism","volume":"vol. 9","author":"Kelly","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.11.004_bib44","unstructured":"P.J. Furlong, Design and synthesis of novel sulphur containing anthracene-9,10-diones, Ph.D., Swansea University (United Kingdom), Ann Arbor, 10805317, 2003. [Online]. Available: Available from ProQuest Dissertations & Theses Global. (2024592163)."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/10255842.2018.1439479","article-title":"Predicting the cardiac toxicity of drugs using a novel multiscale exposure-response simulator","volume":"vol. 21","author":"Sahli Costabal","year":"2018","journal-title":"Comput. Methods Biomech. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.semcancer.2023.11.004_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/CIRCRESAHA.119.316404","article-title":"A computational pipeline to predict cardiotoxicity: from the atom to the rhythm","volume":"vol. 126","author":"Yang","year":"2020","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55032-x","article-title":"Transmural and rate-dependent profiling of drug-induced arrhythmogenic risks through in silico simulations of multichannel pharmacology","volume":"vol. 9","author":"Zhao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.11.004_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4682-6-16","article-title":"A tumor cord model for doxorubicin delivery and dose optimization in solid tumors","volume":"vol. 6","author":"Eikenberry","year":"2009","journal-title":"Theor. Biol. Med Model"},{"issue":"20","key":"10.1016\/j.semcancer.2023.11.004_bib49","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1088\/0031-9155\/59\/20\/5987","article-title":"Modeling localized delivery of Doxorubicin to the brain following focused ultrasound enhanced blood-brain barrier permeability","volume":"vol. 59","author":"Nhan","year":"2014","journal-title":"Phys. Med Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/psp4.12272","article-title":"Translational systems pharmacology-based predictive assessment of drug-induced cardiomyopathy","volume":"vol. 7","author":"Messinis","year":"2018","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"issue":"5","key":"10.1016\/j.semcancer.2023.11.004_bib51","article-title":"Developing a biomechanical model-based elasticity imaging method for assessing hormone receptor positive breast cancer treatment-related myocardial stiffness changes","volume":"vol. 8","author":"Miller","year":"2021","journal-title":"J. Med Imaging (Bellingham"},{"key":"10.1016\/j.semcancer.2023.11.004_bib52","doi-asserted-by":"crossref","first-page":"5636844","DOI":"10.1155\/2022\/5636844","article-title":"Modeling and Analysis of Breast Cancer with Adverse Reactions of Chemotherapy Treatment through Fractional Derivative","volume":"vol. 2022","author":"Tang","year":"2022","journal-title":"Comput. Math. Methods Med"},{"issue":"4","key":"10.1016\/j.semcancer.2023.11.004_bib53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/138920010791514225","article-title":"Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers","volume":"vol. 11","author":"Gonzalez-Diaz","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.semcancer.2023.11.004_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biomaterials.2018.07.062","article-title":"Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system","volume":"vol. 182","author":"Oleaga","year":"2018","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/bcp.12989","article-title":"Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer","volume":"vol. 82","author":"Liang","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00280-016-3090-y","article-title":"Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours","volume":"vol. 78","author":"Patnaik","year":"2016","journal-title":"Cancer Chemother. Pharm."},{"issue":"12","key":"10.1016\/j.semcancer.2023.11.004_bib57","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/psp4.12719","article-title":"A quantitative systems pharmacology approach to predict the safe-equivalent dose of doxorubicin in patients with cardiovascular comorbidity","volume":"vol. 10","author":"Sang","year":"2021","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"issue":"10","key":"10.1016\/j.semcancer.2023.11.004_bib58","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/0006-2952(93)90017-Q","article-title":"A mathematical model of the kinetics and tissue distribution of 2-fluoro-beta-alanine, the major catabolite of 5-fluorouracil","volume":"vol. 45","author":"Zhang","year":"1993","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00280-017-3309-6","article-title":"Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?","volume":"vol. 80","author":"Kunarajah","year":"2017","journal-title":"Cancer Chemother. Pharm."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-020-00417-2","article-title":"Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure","volume":"vol. 21","author":"Siebel","year":"2020","journal-title":"BMC Pharm. Toxicol."},{"issue":"11","key":"10.1016\/j.semcancer.2023.11.004_bib61","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40262-015-0272-4","article-title":"Age-dependent pharmacokinetics of doxorubicin in children with cancer","volume":"vol. 54","author":"Voller","year":"2015","journal-title":"Clin. Pharm."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib62","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-020-00542-0","article-title":"Multiscale and translational quantitative systems toxicology, pharmacokinetic-toxicodynamic modeling analysis for assessment of doxorubicin-induced cardiotoxicity","volume":"vol. 23","author":"Vaidya","year":"2021","journal-title":"AAPS J."},{"issue":"9","key":"10.1016\/j.semcancer.2023.11.004_bib63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11095-018-2456-8","article-title":"A multiscale physiologically-based pharmacokinetic model for doxorubicin to explore its mechanisms of cytotoxicity and cardiotoxicity in human physiological contexts","volume":"vol. 35","author":"He","year":"2018","journal-title":"Pharm. Res"},{"key":"10.1016\/j.semcancer.2023.11.004_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121584","article-title":"Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling","volume":"vol. 286","author":"Kweon","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.semcancer.2023.11.004_bib65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4028\/www.scientific.net\/AMR.1162.144","article-title":"Antioxidant Activity of p-Hidroxy-m-Methoxy Chalcone and its Combination with Doxorubicin: In Vitro and In Silico Study","volume":"vol. 1162","author":"Arianingrum","year":"2021","journal-title":"Adv. Mater. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2023.11.004_bib66","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1021\/acs.jmedchem.0c02157","article-title":"Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIbeta Interactions","volume":"vol. 64","author":"Jirkovska","year":"2021","journal-title":"J. Med Chem."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16943-4","article-title":"Promising anti-leukemic effect of Zataria multiflora extract in combination with doxorubicin to combat acute lymphoblastic leukemia cells (Nalm-6) (in vitro and in silico)","volume":"vol. 12","author":"Lashkari","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.11.004_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114943","article-title":"Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity","volume":"vol. 287","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.semcancer.2023.11.004_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104313","article-title":"Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects","volume":"vol. 146","author":"Li","year":"2019","journal-title":"Pharm. Res"},{"issue":"7","key":"10.1016\/j.semcancer.2023.11.004_bib70","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1016\/j.bmc.2008.01.033","article-title":"The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds","volume":"vol. 16","author":"Hasinoff","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib71","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jpba.2008.07.009","article-title":"Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies","volume":"vol. 48","author":"Cui","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.semcancer.2023.11.004_bib72","first-page":"1761","article-title":"RNA targeting by an anthracycline drug: spectroscopic and in silico evaluation of epirubicin interaction with tRNA","volume":"vol. 38","author":"Charak","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.semcancer.2023.11.004_bib73","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.12.006","article-title":"The Limits of the Linear Quadratic (LQ) Model for Late Cardiotoxicity Prediction: Example of Hypofractionated Rotational Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer","volume":"vol. 106","author":"Loap","year":"2020","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12940-021-00768-1","article-title":"Development of health-based exposure limits for radiofrequency radiation from wireless devices using a benchmark dose approach","volume":"vol. 20","author":"Uche","year":"2021","journal-title":"Environ. Health"},{"key":"10.1016\/j.semcancer.2023.11.004_bib75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2021.02.014","article-title":"Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity","volume":"vol. 155","author":"Grabowska","year":"2021","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2011.74","article-title":"Population pharmacokinetic-pharmacodynamic analysis of trastuzumab-associated cardiotoxicity","volume":"vol. 90","author":"van Hasselt","year":"2011","journal-title":"Clin. Pharm. Ther."},{"issue":"6","key":"10.1016\/j.semcancer.2023.11.004_bib77","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s11095-012-0671-2","article-title":"Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women","volume":"vol. 29","author":"van Hasselt","year":"2012","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.semcancer.2023.11.004_bib78","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-005-1001-8","article-title":"Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin","volume":"vol. 56","author":"Darvari","year":"2005","journal-title":"Cancer Chemother. Pharm."},{"issue":"3","key":"10.1016\/j.semcancer.2023.11.004_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030917","article-title":"A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from Xylopia vielana Targeting B-Raf Kinase","volume":"vol. 27","author":"Hassan","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.semcancer.2023.11.004_bib80","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1871520621666211013115500","article-title":"Computational Exploration of Anti-Cancer Potential of GUAIANE Dimers from Xylopia vielana by Targeting B-Raf Kinase Using Chemo-Informatics, Molecular Docking, and MD Simulation Studies","volume":"vol. 22","author":"Shams Ul Hassan","year":"2022","journal-title":"Anticancer Agents Med Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2023.11.004_bib81","article-title":"Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes","volume":"vol. 13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.semcancer.2023.11.004_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153675","article-title":"Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy","volume":"vol. 13","author":"Matias-Barrios","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2023.11.004_bib83","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14756366.2015.1005011","article-title":"In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors","volume":"vol. 31","author":"Salmas","year":"2016","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"10.1016\/j.semcancer.2023.11.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2021.111002","article-title":"Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors","volume":"vol. 537","author":"van der Vegt","year":"2022","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.semcancer.2023.11.004_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114522","article-title":"Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1\/PD-L1 with benign toxicity profiles for cancer treatment","volume":"vol. 188","author":"Cao","year":"2021","journal-title":"Biochem Pharm."},{"issue":"12","key":"10.1016\/j.semcancer.2023.11.004_bib86","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrclinonc.2015.168","article-title":"Systems biology approaches to adverse drug effects: the example of cardio-oncology","volume":"vol. 12","author":"Brown","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2023.11.004_bib87","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.drudis.2016.02.003","article-title":"Recent developments in using mechanistic cardiac modelling for drug safety evaluation","volume":"vol. 21","author":"Davies","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.semcancer.2023.11.004_bib88","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/bcp.15158","article-title":"Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug-drug-disease interactions with protein kinase inhibitors in cancer-associated venous thromboembolism","volume":"vol. 88","author":"Cheong","year":"2022","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.semcancer.2023.11.004_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00651","article-title":"Mechanistic systems modeling to improve understanding and prediction of cardiotoxicity caused by targeted cancer therapeutics","volume":"vol. 8","author":"Shim","year":"2017","journal-title":"Front Physiol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X23001438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X23001438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:09:36Z","timestamp":1760918976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X23001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":89,"alternative-id":["S1044579X23001438"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2023.11.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical modeling of cardio-oncology: Modeling the systemic effects of cancer therapeutics on the cardiovascular system","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}